nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—Vinca Alkaloids—Vincristine—muscle cancer	0.288	1	CiPCiCtD
Vinblastine—Vincristine—muscle cancer	0.219	1	CrCtD
Vinblastine—Vinorelbine—Vincristine—muscle cancer	0.0515	0.379	CrCrCtD
Vinblastine—Vindesine—Vincristine—muscle cancer	0.0515	0.379	CrCrCtD
Vinblastine—hematologic cancer—muscle cancer	0.0443	0.243	CtDrD
Vinblastine—head and neck cancer—muscle cancer	0.0378	0.207	CtDrD
Vinblastine—Voacamine—Vincristine—muscle cancer	0.0329	0.242	CrCrCtD
Vinblastine—testicular cancer—muscle cancer	0.027	0.148	CtDrD
Vinblastine—germ cell cancer—muscle cancer	0.0259	0.142	CtDrD
Vinblastine—kidney cancer—muscle cancer	0.0241	0.132	CtDrD
Vinblastine—lung cancer—muscle cancer	0.0233	0.128	CtDrD
Vinblastine—ABCC6—Dactinomycin—muscle cancer	0.0138	0.0978	CbGbCtD
Vinblastine—TUBB2A—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB2B—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB8—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB6—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB3—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB4A—Vincristine—muscle cancer	0.0102	0.072	CbGbCtD
Vinblastine—TUBB4B—Vincristine—muscle cancer	0.00851	0.0603	CbGbCtD
Vinblastine—TUBB1—Vincristine—muscle cancer	0.00851	0.0603	CbGbCtD
Vinblastine—TUBB—Vincristine—muscle cancer	0.00851	0.0603	CbGbCtD
Vinblastine—ABCC6—Etoposide—muscle cancer	0.00779	0.0552	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—muscle cancer	0.00532	0.0377	CbGbCtD
Vinblastine—Complete hearing loss—Vincristine—muscle cancer	0.00414	0.281	CcSEcCtD
Vinblastine—ABCC1—Dactinomycin—muscle cancer	0.00407	0.0289	CbGbCtD
Vinblastine—ABCB11—Vincristine—muscle cancer	0.00353	0.025	CbGbCtD
Vinblastine—ABCC1—Vincristine—muscle cancer	0.00251	0.0178	CbGbCtD
Vinblastine—ABCC1—Etoposide—muscle cancer	0.0023	0.0163	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—muscle cancer	0.00221	0.0156	CbGbCtD
Vinblastine—ABCC2—Vincristine—muscle cancer	0.00186	0.0132	CbGbCtD
Vinblastine—ABCC2—Etoposide—muscle cancer	0.0017	0.0121	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—muscle cancer	0.00157	0.0111	CbGbCtD
Vinblastine—ABCC1—Methotrexate—muscle cancer	0.00152	0.0108	CbGbCtD
Vinblastine—ABCC2—Doxorubicin—muscle cancer	0.00116	0.00822	CbGbCtD
Vinblastine—ABCC2—Methotrexate—muscle cancer	0.00112	0.00797	CbGbCtD
Vinblastine—ABCB1—Dactinomycin—muscle cancer	0.000983	0.00696	CbGbCtD
Vinblastine—ABCB1—Vincristine—muscle cancer	0.000605	0.00429	CbGbCtD
Vinblastine—ABCB1—Etoposide—muscle cancer	0.000555	0.00393	CbGbCtD
Vinblastine—ABCC6—Podofilox—Etoposide—muscle cancer	0.00044	1	CbGdCrCtD
Vinblastine—Pain in jaw—Vincristine—muscle cancer	0.000439	0.0298	CcSEcCtD
Vinblastine—ABCB1—Doxorubicin—muscle cancer	0.000378	0.00268	CbGbCtD
Vinblastine—TUBD1—embryo—muscle cancer	0.00037	0.0305	CbGeAlD
Vinblastine—ABCB1—Methotrexate—muscle cancer	0.000367	0.0026	CbGbCtD
Vinblastine—CYP3A4—Vincristine—muscle cancer	0.000363	0.00257	CbGbCtD
Vinblastine—CYP2D6—Doxorubicin—muscle cancer	0.000357	0.00253	CbGbCtD
Vinblastine—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—MYF6—muscle cancer	0.000346	0.0575	CbGpPWpGaD
Vinblastine—Myelosuppression—Dactinomycin—muscle cancer	0.000342	0.0232	CcSEcCtD
Vinblastine—CYP3A4—Etoposide—muscle cancer	0.000332	0.00235	CbGbCtD
Vinblastine—Ileus paralytic—Vincristine—muscle cancer	0.000331	0.0225	CcSEcCtD
Vinblastine—Myelosuppression—Vincristine—muscle cancer	0.000305	0.0207	CcSEcCtD
Vinblastine—TUBG1—PLK1 signaling events—BUB1B—muscle cancer	0.00025	0.0415	CbGpPWpGaD
Vinblastine—Myelosuppression—Etoposide—muscle cancer	0.000247	0.0168	CcSEcCtD
Vinblastine—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.000246	0.0167	CcSEcCtD
Vinblastine—TUBG1—smooth muscle tissue—muscle cancer	0.000244	0.0201	CbGeAlD
Vinblastine—TUBE1—cardiac atrium—muscle cancer	0.000235	0.0194	CbGeAlD
Vinblastine—TUBG1—renal system—muscle cancer	0.000235	0.0193	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—muscle cancer	0.000227	0.00161	CbGbCtD
Vinblastine—TUBD1—tendon—muscle cancer	0.000219	0.018	CbGeAlD
Vinblastine—TUBD1—bone marrow—muscle cancer	0.000212	0.0174	CbGeAlD
Vinblastine—TUBG1—cardiac atrium—muscle cancer	0.000211	0.0173	CbGeAlD
Vinblastine—TUBE1—tendon—muscle cancer	0.000205	0.0169	CbGeAlD
Vinblastine—TUBD1—vagina—muscle cancer	0.000203	0.0167	CbGeAlD
Vinblastine—Ileus—Vincristine—muscle cancer	0.000202	0.0137	CcSEcCtD
Vinblastine—Nystagmus—Vincristine—muscle cancer	0.000201	0.0136	CcSEcCtD
Vinblastine—TUBE1—bone marrow—muscle cancer	0.000199	0.0163	CbGeAlD
Vinblastine—Neuritis—Vincristine—muscle cancer	0.000192	0.013	CcSEcCtD
Vinblastine—TUBE1—vagina—muscle cancer	0.00019	0.0157	CbGeAlD
Vinblastine—TUBB8—head—muscle cancer	0.000188	0.0154	CbGeAlD
Vinblastine—TUBD1—head—muscle cancer	0.000188	0.0154	CbGeAlD
Vinblastine—Extravasation—Dactinomycin—muscle cancer	0.000184	0.0125	CcSEcCtD
Vinblastine—TUBG1—tendon—muscle cancer	0.000184	0.0151	CbGeAlD
Vinblastine—TUBB8—testis—muscle cancer	0.000181	0.0149	CbGeAlD
Vinblastine—TUBD1—testis—muscle cancer	0.000181	0.0149	CbGeAlD
Vinblastine—TUBA1A—embryo—muscle cancer	0.00018	0.0148	CbGeAlD
Vinblastine—JUN—embryo—muscle cancer	0.000178	0.0147	CbGeAlD
Vinblastine—TUBG1—bone marrow—muscle cancer	0.000178	0.0146	CbGeAlD
Vinblastine—TUBE1—head—muscle cancer	0.000176	0.0145	CbGeAlD
Vinblastine—Numbness—Vincristine—muscle cancer	0.000173	0.0117	CcSEcCtD
Vinblastine—TUBG1—vagina—muscle cancer	0.00017	0.014	CbGeAlD
Vinblastine—TUBE1—testis—muscle cancer	0.00017	0.014	CbGeAlD
Vinblastine—Sensory loss—Vincristine—muscle cancer	0.000165	0.0112	CcSEcCtD
Vinblastine—Extravasation—Vincristine—muscle cancer	0.000164	0.0111	CcSEcCtD
Vinblastine—ABCC6—renal system—muscle cancer	0.000161	0.0132	CbGeAlD
Vinblastine—TUBB2A—Signaling events mediated by HDAC Class III—MYOD1—muscle cancer	0.000158	0.0262	CbGpPWpGaD
Vinblastine—TUBG1—head—muscle cancer	0.000157	0.0129	CbGeAlD
Vinblastine—TUBB4A—embryo—muscle cancer	0.000154	0.0126	CbGeAlD
Vinblastine—NR5A1—head—muscle cancer	0.000153	0.0126	CbGeAlD
Vinblastine—TUBG1—testis—muscle cancer	0.000152	0.0125	CbGeAlD
Vinblastine—Bone pain—Vincristine—muscle cancer	0.00015	0.0101	CcSEcCtD
Vinblastine—NR5A1—testis—muscle cancer	0.000148	0.0122	CbGeAlD
Vinblastine—TUBA1A—p73 transcription factor network—TP73—muscle cancer	0.000146	0.0243	CbGpPWpGaD
Vinblastine—TUBA1A—smooth muscle tissue—muscle cancer	0.000141	0.0116	CbGeAlD
Vinblastine—TUBB1—bone marrow—muscle cancer	0.000141	0.0116	CbGeAlD
Vinblastine—JUN—smooth muscle tissue—muscle cancer	0.00014	0.0115	CbGeAlD
Vinblastine—Numbness—Etoposide—muscle cancer	0.00014	0.0095	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.000138	0.023	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—TFE3—muscle cancer	0.000137	0.0228	CbGpPWpGaD
Vinblastine—TUBA1A—renal system—muscle cancer	0.000136	0.0112	CbGeAlD
Vinblastine—Phlebitis—Dactinomycin—muscle cancer	0.000135	0.00917	CcSEcCtD
Vinblastine—JUN—renal system—muscle cancer	0.000135	0.0111	CbGeAlD
Vinblastine—Sensory loss—Etoposide—muscle cancer	0.000134	0.00909	CcSEcCtD
Vinblastine—Extravasation—Etoposide—muscle cancer	0.000133	0.00903	CcSEcCtD
Vinblastine—Myelosuppression—Doxorubicin—muscle cancer	0.000128	0.00871	CcSEcCtD
Vinblastine—TUBB3—head—muscle cancer	0.000128	0.0105	CbGeAlD
Vinblastine—Cellulitis—Etoposide—muscle cancer	0.000128	0.00866	CcSEcCtD
Vinblastine—TUBA1A—p73 transcription factor network—TP63—muscle cancer	0.000126	0.0209	CbGpPWpGaD
Vinblastine—TUBB1—head—muscle cancer	0.000125	0.0103	CbGeAlD
Vinblastine—TUBB3—testis—muscle cancer	0.000124	0.0102	CbGeAlD
Vinblastine—TUBA1A—cardiac atrium—muscle cancer	0.000122	0.01	CbGeAlD
Vinblastine—TUBB1—testis—muscle cancer	0.000121	0.00994	CbGeAlD
Vinblastine—JUN—cardiac atrium—muscle cancer	0.000121	0.00994	CbGeAlD
Vinblastine—TUBB4B—embryo—muscle cancer	0.00012	0.00987	CbGeAlD
Vinblastine—JUN—ATM Signaling Pathway—TP73—muscle cancer	0.000118	0.0196	CbGpPWpGaD
Vinblastine—JUN—Regulation of retinoblastoma protein—PAX3—muscle cancer	0.000117	0.0194	CbGpPWpGaD
Vinblastine—TUBB4A—renal system—muscle cancer	0.000116	0.00957	CbGeAlD
Vinblastine—Deafness—Vincristine—muscle cancer	0.000116	0.00789	CcSEcCtD
Vinblastine—SLC22A2—renal system—muscle cancer	0.000116	0.00953	CbGeAlD
Vinblastine—TUBB2B—renal system—muscle cancer	0.000112	0.00925	CbGeAlD
Vinblastine—TUBA1A—p73 transcription factor network—WT1—muscle cancer	0.000111	0.0184	CbGpPWpGaD
Vinblastine—TUBB—smooth muscle tissue—muscle cancer	0.000111	0.0091	CbGeAlD
Vinblastine—TUBB2A—smooth muscle tissue—muscle cancer	0.00011	0.00905	CbGeAlD
Vinblastine—TUBB6—smooth muscle tissue—muscle cancer	0.000108	0.00892	CbGeAlD
Vinblastine—ABCC6—head—muscle cancer	0.000108	0.00886	CbGeAlD
Vinblastine—TUBB2A—Signaling events mediated by HDAC Class III—FOXO4—muscle cancer	0.000107	0.0178	CbGpPWpGaD
Vinblastine—TUBA1A—tendon—muscle cancer	0.000106	0.00874	CbGeAlD
Vinblastine—JUN—tendon—muscle cancer	0.000105	0.00866	CbGeAlD
Vinblastine—TUBB6—renal system—muscle cancer	0.000104	0.00859	CbGeAlD
Vinblastine—TUBA1A—bone marrow—muscle cancer	0.000103	0.00847	CbGeAlD
Vinblastine—JUN—bone marrow—muscle cancer	0.000102	0.00839	CbGeAlD
Vinblastine—TUBB2B—cardiac atrium—muscle cancer	0.000101	0.00829	CbGeAlD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	9.91e-05	0.0165	CbGpPWpGaD
Vinblastine—TUBA1A—vagina—muscle cancer	9.87e-05	0.00811	CbGeAlD
Vinblastine—NR5A1—Developmental Biology—MYF5—muscle cancer	9.85e-05	0.0164	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—MYF6—muscle cancer	9.85e-05	0.0164	CbGpPWpGaD
Vinblastine—Phlebitis—Etoposide—muscle cancer	9.78e-05	0.00664	CcSEcCtD
Vinblastine—JUN—vagina—muscle cancer	9.77e-05	0.00804	CbGeAlD
Vinblastine—Pancytopenia—Dactinomycin—muscle cancer	9.55e-05	0.00648	CcSEcCtD
Vinblastine—TUBB—cardiac atrium—muscle cancer	9.53e-05	0.00784	CbGeAlD
Vinblastine—TUBB2A—cardiac atrium—muscle cancer	9.48e-05	0.0078	CbGeAlD
Vinblastine—TUBB4B—smooth muscle tissue—muscle cancer	9.43e-05	0.00776	CbGeAlD
Vinblastine—TUBB6—cardiac atrium—muscle cancer	9.35e-05	0.00769	CbGeAlD
Vinblastine—ABCB11—testis—muscle cancer	9.33e-05	0.00768	CbGeAlD
Vinblastine—TUBA1A—head—muscle cancer	9.11e-05	0.0075	CbGeAlD
Vinblastine—TUBB4A—tendon—muscle cancer	9.08e-05	0.00747	CbGeAlD
Vinblastine—TUBB4B—renal system—muscle cancer	9.08e-05	0.00747	CbGeAlD
Vinblastine—JUN—head—muscle cancer	9.02e-05	0.00742	CbGeAlD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	8.92e-05	0.0148	CbGpPWpGaD
Vinblastine—TUBA1A—testis—muscle cancer	8.8e-05	0.00724	CbGeAlD
Vinblastine—TUBB2B—tendon—muscle cancer	8.78e-05	0.00722	CbGeAlD
Vinblastine—JUN—testis—muscle cancer	8.72e-05	0.00717	CbGeAlD
Vinblastine—Pancytopenia—Vincristine—muscle cancer	8.53e-05	0.00579	CcSEcCtD
Vinblastine—Ileus—Doxorubicin—muscle cancer	8.5e-05	0.00577	CcSEcCtD
Vinblastine—Nystagmus—Doxorubicin—muscle cancer	8.42e-05	0.00572	CcSEcCtD
Vinblastine—Agranulocytosis—Dactinomycin—muscle cancer	8.37e-05	0.00568	CcSEcCtD
Vinblastine—TUBB—tendon—muscle cancer	8.31e-05	0.00683	CbGeAlD
Vinblastine—TUBB2A—tendon—muscle cancer	8.27e-05	0.0068	CbGeAlD
Vinblastine—TUBB6—tendon—muscle cancer	8.15e-05	0.00671	CbGeAlD
Vinblastine—TUBB2B—vagina—muscle cancer	8.15e-05	0.0067	CbGeAlD
Vinblastine—TUBB4B—cardiac atrium—muscle cancer	8.13e-05	0.00669	CbGeAlD
Vinblastine—Neuritis—Doxorubicin—muscle cancer	8.06e-05	0.00547	CcSEcCtD
Vinblastine—TUBB—bone marrow—muscle cancer	8.05e-05	0.00662	CbGeAlD
Vinblastine—TUBB2A—bone marrow—muscle cancer	8.01e-05	0.00659	CbGeAlD
Vinblastine—Pharyngitis—Dactinomycin—muscle cancer	7.99e-05	0.00542	CcSEcCtD
Vinblastine—Depression—Vincristine—muscle cancer	7.99e-05	0.00542	CcSEcCtD
Vinblastine—Extravasation—Methotrexate—muscle cancer	7.97e-05	0.00541	CcSEcCtD
Vinblastine—TUBB2A—Signaling events mediated by HDAC Class III—FOXO1—muscle cancer	7.91e-05	0.0131	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Vincristine—muscle cancer	7.9e-05	0.00536	CcSEcCtD
Vinblastine—TUBB6—bone marrow—muscle cancer	7.9e-05	0.00649	CbGeAlD
Vinblastine—Neuropathy peripheral—Vincristine—muscle cancer	7.85e-05	0.00533	CcSEcCtD
Vinblastine—Myocardial infarction—Vincristine—muscle cancer	7.85e-05	0.00533	CcSEcCtD
Vinblastine—TUBB4A—head—muscle cancer	7.79e-05	0.00641	CbGeAlD
Vinblastine—TUBB—vagina—muscle cancer	7.71e-05	0.00634	CbGeAlD
Vinblastine—TUBB2A—vagina—muscle cancer	7.67e-05	0.00631	CbGeAlD
Vinblastine—TUBB6—vagina—muscle cancer	7.56e-05	0.00622	CbGeAlD
Vinblastine—TUBB2B—head—muscle cancer	7.53e-05	0.00619	CbGeAlD
Vinblastine—TUBB4A—testis—muscle cancer	7.52e-05	0.00619	CbGeAlD
Vinblastine—ABCC2—renal system—muscle cancer	7.34e-05	0.00604	CbGeAlD
Vinblastine—TUBB2B—testis—muscle cancer	7.27e-05	0.00598	CbGeAlD
Vinblastine—Hypoaesthesia—Vincristine—muscle cancer	7.16e-05	0.00486	CcSEcCtD
Vinblastine—Alopecia—Dactinomycin—muscle cancer	7.11e-05	0.00483	CcSEcCtD
Vinblastine—TUBB4B—tendon—muscle cancer	7.09e-05	0.00583	CbGeAlD
Vinblastine—TUBB2A—head—muscle cancer	7.08e-05	0.00583	CbGeAlD
Vinblastine—TUBA1A—Metabolism of proteins—TIMM10—muscle cancer	7.03e-05	0.0117	CbGpPWpGaD
Vinblastine—TUBB6—head—muscle cancer	6.99e-05	0.00575	CbGeAlD
Vinblastine—JUN—BDNF signaling pathway—KIDINS220—muscle cancer	6.92e-05	0.0115	CbGpPWpGaD
Vinblastine—Pancytopenia—Etoposide—muscle cancer	6.91e-05	0.00469	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—muscle cancer	6.9e-05	0.00468	CcSEcCtD
Vinblastine—TUBB—testis—muscle cancer	6.88e-05	0.00566	CbGeAlD
Vinblastine—TUBB4B—bone marrow—muscle cancer	6.86e-05	0.00565	CbGeAlD
Vinblastine—TUBB2A—testis—muscle cancer	6.84e-05	0.00563	CbGeAlD
Vinblastine—TUBB6—testis—muscle cancer	6.75e-05	0.00555	CbGeAlD
Vinblastine—Rectal haemorrhage—Doxorubicin—muscle cancer	6.66e-05	0.00452	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—muscle cancer	6.62e-05	0.00449	CcSEcCtD
Vinblastine—TUBB4B—vagina—muscle cancer	6.58e-05	0.00541	CbGeAlD
Vinblastine—Ill-defined disorder—Dactinomycin—muscle cancer	6.5e-05	0.00441	CcSEcCtD
Vinblastine—JUN—Apoptosis—TP73—muscle cancer	6.5e-05	0.0108	CbGpPWpGaD
Vinblastine—Anaemia—Dactinomycin—muscle cancer	6.48e-05	0.0044	CcSEcCtD
Vinblastine—JUN—Regulation of retinoblastoma protein—MYOD1—muscle cancer	6.43e-05	0.0107	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Etoposide—muscle cancer	6.4e-05	0.00434	CcSEcCtD
Vinblastine—Neuropathy peripheral—Etoposide—muscle cancer	6.36e-05	0.00432	CcSEcCtD
Vinblastine—Myocardial infarction—Etoposide—muscle cancer	6.36e-05	0.00432	CcSEcCtD
Vinblastine—Alopecia—Vincristine—muscle cancer	6.36e-05	0.00431	CcSEcCtD
Vinblastine—NR5A1—Developmental Biology—MYOG—muscle cancer	6.35e-05	0.0105	CbGpPWpGaD
Vinblastine—Malaise—Dactinomycin—muscle cancer	6.32e-05	0.00429	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—muscle cancer	6.28e-05	0.00426	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—muscle cancer	6.28e-05	0.00426	CcSEcCtD
Vinblastine—Leukopenia—Dactinomycin—muscle cancer	6.27e-05	0.00426	CcSEcCtD
Vinblastine—TUBB4B—head—muscle cancer	6.07e-05	0.005	CbGeAlD
Vinblastine—Agranulocytosis—Etoposide—muscle cancer	6.06e-05	0.00411	CcSEcCtD
Vinblastine—Discomfort—Dactinomycin—muscle cancer	5.89e-05	0.004	CcSEcCtD
Vinblastine—TUBB4B—testis—muscle cancer	5.87e-05	0.00483	CbGeAlD
Vinblastine—JUN—Regulation of Telomerase—WT1—muscle cancer	5.84e-05	0.00969	CbGpPWpGaD
Vinblastine—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	5.8e-05	0.00964	CbGpPWpGaD
Vinblastine—Hypoaesthesia—Etoposide—muscle cancer	5.8e-05	0.00393	CcSEcCtD
Vinblastine—ABCC1—cardiac atrium—muscle cancer	5.79e-05	0.00476	CbGeAlD
Vinblastine—Anaemia—Vincristine—muscle cancer	5.79e-05	0.00393	CcSEcCtD
Vinblastine—ABCC2—tendon—muscle cancer	5.73e-05	0.00471	CbGeAlD
Vinblastine—TUBB6—Metabolism of proteins—TIMM10—muscle cancer	5.65e-05	0.00939	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—TIMM10—muscle cancer	5.65e-05	0.00939	CbGpPWpGaD
Vinblastine—Vertigo—Vincristine—muscle cancer	5.63e-05	0.00382	CcSEcCtD
Vinblastine—Leukopenia—Vincristine—muscle cancer	5.6e-05	0.0038	CcSEcCtD
Vinblastine—Thrombocytopenia—Dactinomycin—muscle cancer	5.6e-05	0.0038	CcSEcCtD
Vinblastine—JUN—Apoptosis—TP63—muscle cancer	5.59e-05	0.00929	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—TIMM10—muscle cancer	5.46e-05	0.00907	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	5.46e-05	0.00906	CbGpPWpGaD
Vinblastine—Anorexia—Dactinomycin—muscle cancer	5.45e-05	0.0037	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—muscle cancer	5.44e-05	0.00369	CcSEcCtD
Vinblastine—Convulsion—Vincristine—muscle cancer	5.43e-05	0.00368	CcSEcCtD
Vinblastine—Hypertension—Vincristine—muscle cancer	5.41e-05	0.00367	CcSEcCtD
Vinblastine—TUBB2A—Metabolism of proteins—TIMM10—muscle cancer	5.29e-05	0.00879	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TP73—muscle cancer	5.28e-05	0.00877	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—TIMM10—muscle cancer	5.17e-05	0.00859	CbGpPWpGaD
Vinblastine—Alopecia—Etoposide—muscle cancer	5.15e-05	0.00349	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—muscle cancer	5.15e-05	0.00349	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—muscle cancer	5.07e-05	0.00344	CcSEcCtD
Vinblastine—ABCC1—tendon—muscle cancer	5.05e-05	0.00415	CbGeAlD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	5.04e-05	0.00837	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Vincristine—muscle cancer	5e-05	0.0034	CcSEcCtD
Vinblastine—Decreased appetite—Dactinomycin—muscle cancer	4.97e-05	0.00337	CcSEcCtD
Vinblastine—Pain—Dactinomycin—muscle cancer	4.89e-05	0.00332	CcSEcCtD
Vinblastine—Anorexia—Vincristine—muscle cancer	4.87e-05	0.00331	CcSEcCtD
Vinblastine—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	4.81e-05	0.00799	CbGpPWpGaD
Vinblastine—ABCC2—testis—muscle cancer	4.75e-05	0.0039	CbGeAlD
Vinblastine—Feeling abnormal—Dactinomycin—muscle cancer	4.71e-05	0.0032	CcSEcCtD
Vinblastine—Ill-defined disorder—Etoposide—muscle cancer	4.71e-05	0.00319	CcSEcCtD
Vinblastine—Anaemia—Etoposide—muscle cancer	4.69e-05	0.00318	CcSEcCtD
Vinblastine—ABCC1—vagina—muscle cancer	4.68e-05	0.00385	CbGeAlD
Vinblastine—Gastrointestinal pain—Dactinomycin—muscle cancer	4.68e-05	0.00317	CcSEcCtD
Vinblastine—JUN—Direct p53 effectors—PMS2—muscle cancer	4.65e-05	0.00772	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—TIMM10—muscle cancer	4.64e-05	0.00771	CbGpPWpGaD
Vinblastine—Paraesthesia—Vincristine—muscle cancer	4.59e-05	0.00311	CcSEcCtD
Vinblastine—Malaise—Etoposide—muscle cancer	4.57e-05	0.0031	CcSEcCtD
Vinblastine—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	4.57e-05	0.00759	CbGpPWpGaD
Vinblastine—Vertigo—Etoposide—muscle cancer	4.56e-05	0.00309	CcSEcCtD
Vinblastine—Leukopenia—Etoposide—muscle cancer	4.54e-05	0.00308	CcSEcCtD
Vinblastine—Abdominal pain—Dactinomycin—muscle cancer	4.52e-05	0.00307	CcSEcCtD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	4.47e-05	0.00742	CbGpPWpGaD
Vinblastine—Cerebrovascular accident—Doxorubicin—muscle cancer	4.46e-05	0.00303	CcSEcCtD
Vinblastine—Decreased appetite—Vincristine—muscle cancer	4.44e-05	0.00301	CcSEcCtD
Vinblastine—Convulsion—Etoposide—muscle cancer	4.39e-05	0.00298	CcSEcCtD
Vinblastine—Hypertension—Etoposide—muscle cancer	4.38e-05	0.00297	CcSEcCtD
Vinblastine—Constipation—Vincristine—muscle cancer	4.37e-05	0.00297	CcSEcCtD
Vinblastine—Pain—Vincristine—muscle cancer	4.37e-05	0.00297	CcSEcCtD
Vinblastine—JUN—AGE/RAGE pathway—FOXO4—muscle cancer	4.37e-05	0.00726	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP73—muscle cancer	4.32e-05	0.00718	CbGpPWpGaD
Vinblastine—Discomfort—Etoposide—muscle cancer	4.27e-05	0.0029	CcSEcCtD
Vinblastine—TUBB4B—Metabolism of proteins—TIMM10—muscle cancer	4.25e-05	0.00706	CbGpPWpGaD
Vinblastine—JUN—IL6-mediated signaling events—FOXO1—muscle cancer	4.23e-05	0.00703	CbGpPWpGaD
Vinblastine—Hypersensitivity—Dactinomycin—muscle cancer	4.21e-05	0.00286	CcSEcCtD
Vinblastine—ABCC1—testis—muscle cancer	4.18e-05	0.00344	CbGeAlD
Vinblastine—Gastrointestinal pain—Vincristine—muscle cancer	4.18e-05	0.00284	CcSEcCtD
Vinblastine—ABCC1—S1P1 pathway—PTGS2—muscle cancer	4.17e-05	0.00693	CbGpPWpGaD
Vinblastine—Pancytopenia—Methotrexate—muscle cancer	4.14e-05	0.00281	CcSEcCtD
Vinblastine—Asthenia—Dactinomycin—muscle cancer	4.1e-05	0.00279	CcSEcCtD
Vinblastine—Thrombocytopenia—Etoposide—muscle cancer	4.05e-05	0.00275	CcSEcCtD
Vinblastine—Abdominal pain—Vincristine—muscle cancer	4.04e-05	0.00274	CcSEcCtD
Vinblastine—JUN—SIDS Susceptibility Pathways—TP73—muscle cancer	3.96e-05	0.00658	CbGpPWpGaD
Vinblastine—Anorexia—Etoposide—muscle cancer	3.95e-05	0.00268	CcSEcCtD
Vinblastine—NR5A1—Developmental Biology—MYOD1—muscle cancer	3.92e-05	0.00651	CbGpPWpGaD
Vinblastine—Diarrhoea—Dactinomycin—muscle cancer	3.91e-05	0.00266	CcSEcCtD
Vinblastine—JUN—Copper homeostasis—FOXO1—muscle cancer	3.91e-05	0.00649	CbGpPWpGaD
Vinblastine—Depression—Methotrexate—muscle cancer	3.88e-05	0.00263	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle, Mitotic—BUB1B—muscle cancer	3.87e-05	0.00643	CbGpPWpGaD
Vinblastine—JUN—Regulation of Androgen receptor activity—FOXO1—muscle cancer	3.85e-05	0.00639	CbGpPWpGaD
Vinblastine—NR5A1—Generic Transcription Pathway—MED12—muscle cancer	3.81e-05	0.00633	CbGpPWpGaD
Vinblastine—JUN—ErbB Signaling Pathway—FOXO1—muscle cancer	3.79e-05	0.00629	CbGpPWpGaD
Vinblastine—Hypersensitivity—Vincristine—muscle cancer	3.77e-05	0.00256	CcSEcCtD
Vinblastine—CYP3A4—renal system—muscle cancer	3.73e-05	0.00307	CbGeAlD
Vinblastine—Paraesthesia—Etoposide—muscle cancer	3.72e-05	0.00252	CcSEcCtD
Vinblastine—JUN—Direct p53 effectors—TP63—muscle cancer	3.72e-05	0.00617	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	3.71e-05	0.00616	CbGpPWpGaD
Vinblastine—Angina pectoris—Doxorubicin—muscle cancer	3.68e-05	0.0025	CcSEcCtD
Vinblastine—CYP2D6—renal system—muscle cancer	3.67e-05	0.00302	CbGeAlD
Vinblastine—Asthenia—Vincristine—muscle cancer	3.67e-05	0.00249	CcSEcCtD
Vinblastine—Vomiting—Dactinomycin—muscle cancer	3.64e-05	0.00247	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—muscle cancer	3.63e-05	0.00246	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—PTGS2—muscle cancer	3.6e-05	0.00599	CbGpPWpGaD
Vinblastine—Decreased appetite—Etoposide—muscle cancer	3.6e-05	0.00244	CcSEcCtD
Vinblastine—TUBA1A—p73 transcription factor network—MDM2—muscle cancer	3.59e-05	0.00596	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—MED12—muscle cancer	3.59e-05	0.00596	CbGpPWpGaD
Vinblastine—Pancytopenia—Doxorubicin—muscle cancer	3.59e-05	0.00243	CcSEcCtD
Vinblastine—Pain—Etoposide—muscle cancer	3.54e-05	0.0024	CcSEcCtD
Vinblastine—Constipation—Etoposide—muscle cancer	3.54e-05	0.0024	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—muscle cancer	3.51e-05	0.00238	CcSEcCtD
Vinblastine—Diarrhoea—Vincristine—muscle cancer	3.5e-05	0.00237	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—muscle cancer	3.49e-05	0.00237	CcSEcCtD
Vinblastine—ABCB1—embryo—muscle cancer	3.49e-05	0.00287	CbGeAlD
Vinblastine—Pharyngitis—Methotrexate—muscle cancer	3.46e-05	0.00235	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle—BUB1B—muscle cancer	3.46e-05	0.00575	CbGpPWpGaD
Vinblastine—Feeling abnormal—Etoposide—muscle cancer	3.41e-05	0.00232	CcSEcCtD
Vinblastine—Nausea—Dactinomycin—muscle cancer	3.4e-05	0.00231	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etoposide—muscle cancer	3.39e-05	0.0023	CcSEcCtD
Vinblastine—Dizziness—Vincristine—muscle cancer	3.38e-05	0.00229	CcSEcCtD
Vinblastine—JUN—Senescence and Autophagy in Cancer—HMGA1—muscle cancer	3.36e-05	0.00558	CbGpPWpGaD
Vinblastine—Neuropathy peripheral—Doxorubicin—muscle cancer	3.3e-05	0.00224	CcSEcCtD
Vinblastine—ABCC1—S1P1 pathway—VEGFA—muscle cancer	3.29e-05	0.00546	CbGpPWpGaD
Vinblastine—Abdominal pain—Etoposide—muscle cancer	3.27e-05	0.00222	CcSEcCtD
Vinblastine—Vomiting—Vincristine—muscle cancer	3.25e-05	0.00221	CcSEcCtD
Vinblastine—JUN—AGE/RAGE pathway—FOXO1—muscle cancer	3.23e-05	0.00536	CbGpPWpGaD
Vinblastine—Headache—Vincristine—muscle cancer	3.2e-05	0.00217	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—muscle cancer	3.17e-05	0.00527	CbGpPWpGaD
Vinblastine—Agranulocytosis—Doxorubicin—muscle cancer	3.14e-05	0.00213	CcSEcCtD
Vinblastine—JUN—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	3.1e-05	0.00515	CbGpPWpGaD
Vinblastine—Alopecia—Methotrexate—muscle cancer	3.08e-05	0.00209	CcSEcCtD
Vinblastine—Hypersensitivity—Etoposide—muscle cancer	3.05e-05	0.00207	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—muscle cancer	3.04e-05	0.00206	CcSEcCtD
Vinblastine—Nausea—Vincristine—muscle cancer	3.04e-05	0.00206	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—muscle cancer	3.02e-05	0.00205	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—muscle cancer	3.01e-05	0.00204	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—muscle cancer	3e-05	0.00204	CcSEcCtD
Vinblastine—Asthenia—Etoposide—muscle cancer	2.97e-05	0.00202	CcSEcCtD
Vinblastine—JUN—Apoptosis—IGF2—muscle cancer	2.89e-05	0.0048	CbGpPWpGaD
Vinblastine—JUN—ATM Signaling Pathway—MDM2—muscle cancer	2.89e-05	0.0048	CbGpPWpGaD
Vinblastine—Diarrhoea—Etoposide—muscle cancer	2.83e-05	0.00192	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—muscle cancer	2.82e-05	0.00191	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—muscle cancer	2.81e-05	0.00191	CcSEcCtD
Vinblastine—Malaise—Methotrexate—muscle cancer	2.74e-05	0.00186	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	2.74e-05	0.00455	CbGpPWpGaD
Vinblastine—Dizziness—Etoposide—muscle cancer	2.74e-05	0.00186	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—muscle cancer	2.73e-05	0.00185	CcSEcCtD
Vinblastine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—muscle cancer	2.72e-05	0.00453	CbGpPWpGaD
Vinblastine—Leukopenia—Methotrexate—muscle cancer	2.72e-05	0.00185	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—muscle cancer	2.67e-05	0.00181	CcSEcCtD
Vinblastine—ABCB1—renal system—muscle cancer	2.64e-05	0.00217	CbGeAlD
Vinblastine—Convulsion—Methotrexate—muscle cancer	2.63e-05	0.00179	CcSEcCtD
Vinblastine—Vomiting—Etoposide—muscle cancer	2.63e-05	0.00179	CcSEcCtD
Vinblastine—Headache—Etoposide—muscle cancer	2.59e-05	0.00176	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—muscle cancer	2.56e-05	0.00173	CcSEcCtD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.55e-05	0.00424	CbGpPWpGaD
Vinblastine—JUN—Androgen receptor signaling pathway—FOXO1—muscle cancer	2.54e-05	0.00422	CbGpPWpGaD
Vinblastine—Nausea—Etoposide—muscle cancer	2.46e-05	0.00167	CcSEcCtD
Vinblastine—CYP2D6—head—muscle cancer	2.46e-05	0.00202	CbGeAlD
Vinblastine—Ill-defined disorder—Doxorubicin—muscle cancer	2.44e-05	0.00166	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—muscle cancer	2.43e-05	0.00165	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—muscle cancer	2.43e-05	0.00165	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—muscle cancer	2.37e-05	0.00161	CcSEcCtD
Vinblastine—CYP2D6—testis—muscle cancer	2.37e-05	0.00195	CbGeAlD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—FOXO1—muscle cancer	2.37e-05	0.00394	CbGpPWpGaD
Vinblastine—Vertigo—Doxorubicin—muscle cancer	2.36e-05	0.0016	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—muscle cancer	2.36e-05	0.0016	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—muscle cancer	2.35e-05	0.0016	CcSEcCtD
Vinblastine—JUN—Copper homeostasis—MDM2—muscle cancer	2.34e-05	0.00389	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—muscle cancer	2.33e-05	0.00387	CbGpPWpGaD
Vinblastine—JUN—Regulation of Androgen receptor activity—MDM2—muscle cancer	2.31e-05	0.00383	CbGpPWpGaD
Vinblastine—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	2.31e-05	0.00383	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—CNR1—muscle cancer	2.3e-05	0.00382	CbGpPWpGaD
Vinblastine—Convulsion—Doxorubicin—muscle cancer	2.28e-05	0.00155	CcSEcCtD
Vinblastine—JUN—ErbB Signaling Pathway—MDM2—muscle cancer	2.27e-05	0.00378	CbGpPWpGaD
Vinblastine—Hypertension—Doxorubicin—muscle cancer	2.27e-05	0.00154	CcSEcCtD
Vinblastine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	2.26e-05	0.00376	CbGpPWpGaD
Vinblastine—Paraesthesia—Methotrexate—muscle cancer	2.23e-05	0.00151	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—muscle cancer	2.21e-05	0.0015	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—muscle cancer	2.16e-05	0.00146	CcSEcCtD
Vinblastine—JUN—Pre-NOTCH Transcription and Translation—TP53—muscle cancer	2.15e-05	0.00356	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	2.13e-05	0.00354	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—HMGA1—muscle cancer	2.13e-05	0.00353	CbGpPWpGaD
Vinblastine—Pain—Methotrexate—muscle cancer	2.12e-05	0.00144	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—muscle cancer	2.1e-05	0.00143	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—muscle cancer	2.05e-05	0.00139	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—muscle cancer	2.04e-05	0.00139	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—muscle cancer	2.03e-05	0.00138	CcSEcCtD
Vinblastine—JUN—Regulation of retinoblastoma protein—CDKN2A—muscle cancer	2e-05	0.00332	CbGpPWpGaD
Vinblastine—ABCB1—bone marrow—muscle cancer	2e-05	0.00164	CbGeAlD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	1.98e-05	0.0033	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—FOXO1—muscle cancer	1.97e-05	0.00327	CbGpPWpGaD
Vinblastine—Abdominal pain—Methotrexate—muscle cancer	1.96e-05	0.00133	CcSEcCtD
Vinblastine—JUN—Regulation of retinoblastoma protein—MDM2—muscle cancer	1.94e-05	0.00322	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—BUB1B—muscle cancer	1.94e-05	0.00321	CbGpPWpGaD
Vinblastine—Paraesthesia—Doxorubicin—muscle cancer	1.93e-05	0.00131	CcSEcCtD
Vinblastine—ABCC1—Arachidonic acid metabolism—PTGS2—muscle cancer	1.92e-05	0.0032	CbGpPWpGaD
Vinblastine—ABCB1—vagina—muscle cancer	1.91e-05	0.00157	CbGeAlD
Vinblastine—JUN—AP-1 transcription factor network—CDKN2A—muscle cancer	1.9e-05	0.00316	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	1.87e-05	0.0031	CbGpPWpGaD
Vinblastine—Decreased appetite—Doxorubicin—muscle cancer	1.87e-05	0.00127	CcSEcCtD
Vinblastine—JUN—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	1.85e-05	0.00307	CbGpPWpGaD
Vinblastine—Pain—Doxorubicin—muscle cancer	1.84e-05	0.00125	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—muscle cancer	1.84e-05	0.00125	CcSEcCtD
Vinblastine—NR5A1—Gene Expression—MED12—muscle cancer	1.83e-05	0.00305	CbGpPWpGaD
Vinblastine—Hypersensitivity—Methotrexate—muscle cancer	1.83e-05	0.00124	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—muscle cancer	1.78e-05	0.00121	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	1.77e-05	0.00294	CbGpPWpGaD
Vinblastine—Feeling abnormal—Doxorubicin—muscle cancer	1.77e-05	0.0012	CcSEcCtD
Vinblastine—ABCB1—head—muscle cancer	1.77e-05	0.00145	CbGeAlD
Vinblastine—Gastrointestinal pain—Doxorubicin—muscle cancer	1.76e-05	0.00119	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle—BUB1B—muscle cancer	1.73e-05	0.00287	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	1.71e-05	0.00284	CbGpPWpGaD
Vinblastine—ABCB1—testis—muscle cancer	1.71e-05	0.0014	CbGeAlD
Vinblastine—Abdominal pain—Doxorubicin—muscle cancer	1.7e-05	0.00115	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—muscle cancer	1.7e-05	0.00115	CcSEcCtD
Vinblastine—JUN—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	1.66e-05	0.00276	CbGpPWpGaD
Vinblastine—JUN—ATM Signaling Pathway—TP53—muscle cancer	1.66e-05	0.00276	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—CDKN2A—muscle cancer	1.65e-05	0.00273	CbGpPWpGaD
Vinblastine—Dizziness—Methotrexate—muscle cancer	1.64e-05	0.00111	CcSEcCtD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	1.63e-05	0.0027	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—HMGA1—muscle cancer	1.61e-05	0.00267	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—MDM2—muscle cancer	1.6e-05	0.00265	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—FOXO1—muscle cancer	1.59e-05	0.00264	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—CDKN2A—muscle cancer	1.58e-05	0.00263	CbGpPWpGaD
Vinblastine—Hypersensitivity—Doxorubicin—muscle cancer	1.58e-05	0.00107	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—muscle cancer	1.58e-05	0.00107	CcSEcCtD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	1.57e-05	0.00261	CbGpPWpGaD
Vinblastine—Headache—Methotrexate—muscle cancer	1.55e-05	0.00105	CcSEcCtD
Vinblastine—JUN—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	1.54e-05	0.00256	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—BUB1B—muscle cancer	1.54e-05	0.00256	CbGpPWpGaD
Vinblastine—Asthenia—Doxorubicin—muscle cancer	1.54e-05	0.00105	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle—MDM2—muscle cancer	1.53e-05	0.00255	CbGpPWpGaD
Vinblastine—JUN—Androgen receptor signaling pathway—MDM2—muscle cancer	1.52e-05	0.00253	CbGpPWpGaD
Vinblastine—JUN—Pre-NOTCH Expression and Processing—TP53—muscle cancer	1.51e-05	0.00251	CbGpPWpGaD
Vinblastine—Nausea—Methotrexate—muscle cancer	1.47e-05	0.001	CcSEcCtD
Vinblastine—JUN—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.47e-05	0.00244	CbGpPWpGaD
Vinblastine—Diarrhoea—Doxorubicin—muscle cancer	1.47e-05	0.000997	CcSEcCtD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	1.47e-05	0.00243	CbGpPWpGaD
Vinblastine—Dizziness—Doxorubicin—muscle cancer	1.42e-05	0.000964	CcSEcCtD
Vinblastine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.39e-05	0.00232	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—BUB1B—muscle cancer	1.38e-05	0.00229	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—muscle cancer	1.38e-05	0.00229	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—CDKN2A—muscle cancer	1.38e-05	0.00229	CbGpPWpGaD
Vinblastine—Vomiting—Doxorubicin—muscle cancer	1.37e-05	0.000927	CcSEcCtD
Vinblastine—Headache—Doxorubicin—muscle cancer	1.35e-05	0.000913	CcSEcCtD
Vinblastine—JUN—Copper homeostasis—TP53—muscle cancer	1.34e-05	0.00223	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—CDKN2A—muscle cancer	1.34e-05	0.00222	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—MDM2—muscle cancer	1.34e-05	0.00222	CbGpPWpGaD
Vinblastine—JUN—ErbB Signaling Pathway—TP53—muscle cancer	1.3e-05	0.00217	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—MDM2—muscle cancer	1.3e-05	0.00215	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—BUB1B—muscle cancer	1.28e-05	0.00212	CbGpPWpGaD
Vinblastine—Nausea—Doxorubicin—muscle cancer	1.28e-05	0.000866	CcSEcCtD
Vinblastine—JUN—Oxidative Stress Induced Senescence—CDKN2A—muscle cancer	1.25e-05	0.00207	CbGpPWpGaD
Vinblastine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	1.24e-05	0.00205	CbGpPWpGaD
Vinblastine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	1.23e-05	0.00204	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—MDM2—muscle cancer	1.21e-05	0.00201	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—BUB1B—muscle cancer	1.17e-05	0.00194	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—IGF2—muscle cancer	1.16e-05	0.00192	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.15e-05	0.00192	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—BUB1B—muscle cancer	1.14e-05	0.0019	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	1.12e-05	0.00186	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—MDM2—muscle cancer	1.06e-05	0.00176	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—TP53—muscle cancer	1.06e-05	0.00176	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—BUB1B—muscle cancer	1.04e-05	0.00174	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	1e-05	0.00167	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—MDM2—muscle cancer	9.99e-06	0.00166	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—TP53—muscle cancer	9.34e-06	0.00155	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—IGF2—muscle cancer	9.31e-06	0.00155	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—IGF2—muscle cancer	9.31e-06	0.00155	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TP53—muscle cancer	9.16e-06	0.00152	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—FH—muscle cancer	9.09e-06	0.00151	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—IGF2—muscle cancer	8.99e-06	0.00149	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—VEGFA—muscle cancer	8.97e-06	0.00149	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CDKN2A—muscle cancer	8.84e-06	0.00147	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—TP53—muscle cancer	8.81e-06	0.00146	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	8.8e-06	0.00146	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—CDKN2A—muscle cancer	8.72e-06	0.00145	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—IGF2—muscle cancer	8.71e-06	0.00145	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.66e-06	0.00144	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TP53—muscle cancer	8.59e-06	0.00143	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIDINS220—muscle cancer	8.58e-06	0.00142	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—IGF2—muscle cancer	8.51e-06	0.00141	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—MDM2—muscle cancer	8.45e-06	0.0014	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.28e-06	0.00137	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	7.98e-06	0.00133	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CDKN2A—muscle cancer	7.91e-06	0.00131	CbGpPWpGaD
Vinblastine—JUN—Wnt Signaling Pathway and Pluripotency—TP53—muscle cancer	7.84e-06	0.0013	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—FOXO4—muscle cancer	7.71e-06	0.00128	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—MDM2—muscle cancer	7.67e-06	0.00127	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—TP53—muscle cancer	7.66e-06	0.00127	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—IGF2—muscle cancer	7.64e-06	0.00127	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	7.58e-06	0.00126	CbGpPWpGaD
Vinblastine—JUN—Signaling by NOTCH—TP53—muscle cancer	7.44e-06	0.00124	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	7.44e-06	0.00124	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—VEGFA—muscle cancer	7.39e-06	0.00123	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.34e-06	0.00122	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—CDKN2A—muscle cancer	7.05e-06	0.00117	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—IGF2—muscle cancer	6.99e-06	0.00116	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—TP53—muscle cancer	6.93e-06	0.00115	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—FH—muscle cancer	6.83e-06	0.00113	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD34—muscle cancer	6.61e-06	0.0011	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—CDKN2A—muscle cancer	6.59e-06	0.00109	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—MDM2—muscle cancer	6.39e-06	0.00106	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TP53—muscle cancer	6.38e-06	0.00106	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—VEGFA—muscle cancer	6.31e-06	0.00105	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CDKN2A—muscle cancer	6.3e-06	0.00105	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.28e-06	0.00104	CbGpPWpGaD
Vinblastine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	6.26e-06	0.00104	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MDM2—muscle cancer	6.11e-06	0.00102	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP53—muscle cancer	6.09e-06	0.00101	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—FH—muscle cancer	5.95e-06	0.000988	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—muscle cancer	5.84e-06	0.00097	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	5.78e-06	0.00096	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	5.74e-06	0.000953	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—TP53—muscle cancer	5.73e-06	0.000952	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—FOXO1—muscle cancer	5.7e-06	0.000946	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—muscle cancer	5.34e-06	0.000887	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TP53—muscle cancer	5.26e-06	0.000874	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CDKN2A—muscle cancer	5.22e-06	0.000867	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—MED12—muscle cancer	5.14e-06	0.000853	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MDM2—muscle cancer	5.06e-06	0.000841	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	5e-06	0.000831	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—VEGFA—muscle cancer	4.85e-06	0.000806	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—TP53—muscle cancer	4.85e-06	0.000806	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CDKN2A—muscle cancer	4.77e-06	0.000793	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.75e-06	0.000789	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ENO2—muscle cancer	4.68e-06	0.000778	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MDM2—muscle cancer	4.63e-06	0.000769	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TP53—muscle cancer	4.56e-06	0.000757	CbGpPWpGaD
Vinblastine—JUN—Immune System—FOXO4—muscle cancer	4.49e-06	0.000746	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TP53—muscle cancer	4.4e-06	0.000731	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—MDM2—muscle cancer	4.39e-06	0.00073	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KIT—muscle cancer	4.34e-06	0.000721	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ENO2—muscle cancer	4.2e-06	0.000698	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MED12—muscle cancer	3.86e-06	0.000641	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HMGA1—muscle cancer	3.82e-06	0.000634	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—muscle cancer	3.67e-06	0.000609	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.66e-06	0.000608	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ENO2—muscle cancer	3.52e-06	0.000584	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—muscle cancer	3.51e-06	0.000582	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FOXO4—muscle cancer	3.42e-06	0.000569	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MDM2—muscle cancer	3.42e-06	0.000568	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTCH1—muscle cancer	3.38e-06	0.000561	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MED12—muscle cancer	3.36e-06	0.000558	CbGpPWpGaD
Vinblastine—JUN—Immune System—FOXO1—muscle cancer	3.32e-06	0.000551	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.25e-06	0.00054	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—FH—muscle cancer	3.25e-06	0.00054	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.13e-06	0.000521	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ENO2—muscle cancer	3.06e-06	0.000509	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FH—muscle cancer	3.06e-06	0.000509	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—muscle cancer	2.91e-06	0.000483	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FOXO4—muscle cancer	2.9e-06	0.000482	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CNR1—muscle cancer	2.85e-06	0.000473	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.75e-06	0.000457	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—muscle cancer	2.66e-06	0.000441	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FOXO1—muscle cancer	2.53e-06	0.00042	CbGpPWpGaD
Vinblastine—JUN—Immune System—KIT—muscle cancer	2.53e-06	0.00042	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.47e-06	0.00041	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF2—muscle cancer	2.33e-06	0.000387	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FOXO1—muscle cancer	2.14e-06	0.000356	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FH—muscle cancer	2e-06	0.000332	CbGpPWpGaD
Vinblastine—JUN—Immune System—MDM2—muscle cancer	1.99e-06	0.000331	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KIT—muscle cancer	1.93e-06	0.00032	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.87e-06	0.00031	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MED12—muscle cancer	1.84e-06	0.000305	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MED12—muscle cancer	1.73e-06	0.000287	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ENO2—muscle cancer	1.67e-06	0.000278	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIT—muscle cancer	1.63e-06	0.000271	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—muscle cancer	1.63e-06	0.000271	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ENO2—muscle cancer	1.58e-06	0.000262	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MDM2—muscle cancer	1.52e-06	0.000252	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—muscle cancer	1.46e-06	0.000243	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MDM2—muscle cancer	1.29e-06	0.000214	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—muscle cancer	1.23e-06	0.000204	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MED12—muscle cancer	1.13e-06	0.000188	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—muscle cancer	1.07e-06	0.000177	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ENO2—muscle cancer	1.03e-06	0.000171	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—muscle cancer	9.77e-07	0.000162	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—muscle cancer	7.38e-07	0.000123	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—muscle cancer	5.83e-07	9.68e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—muscle cancer	5.49e-07	9.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—muscle cancer	3.59e-07	5.97e-05	CbGpPWpGaD
